The use of a restricted access volatile supramolecular solvent for the LC/MS-MS assay of bisphenol A in urine with a significant reduction of phospholipid-based matrix effects.
Restricted access-volatile supramolecular solvents (RAM-VOL-SUPRAS) are here proposed as a new strategy for the quick removal of protein and phospholipids and efficient analyte extraction in LC-MS bioanalysis. Quantification of bisphenol A in urine was selected to prove the suitability of this approach for the intended purpose. RAM-VOL-SUPRAS were spontaneously synthesized in urine by addition of hexanol (83 μL) dissolved in THF (150 μL). SUPRAS composition was environment-dependent and an equation for prediction of SUPRAS volume under given experimental conditions was proposed. Urinary proteins were removed by flocculation by the combined action of THF and hexanol. Phospholipids were extracted in the SUPRAS by the formation of mixed aggregates with hexanol and precipitated as the SUPRAS extract (75 μL) was evaporated to dryness. BPA, re-extracted from the residue, was analysed by LC-(ESI)-MS/MS. Removal of phospholipids by precipitation was proved by monitoring them in both evaporated and unevaporated urine SUPRAS extracts by LC-MS. This removal led to significant reduction in matrix-effects in the determination of BPA. The method quantification limit in urine was 0.025 ng mL-1 and the repeatability for 0.4 ng mL-1 of BPA, expressed as relative standard deviation, was 4.5%. Concentrations of BPA in the urine samples analysed were in the range 0.357-1.58 ng mL-1. Recoveries were within the range 96-107%. This new approach for sample treatment in bioanalysis, based on the simplicity of dual precipitation of proteins and phospholipids, allows obtaining much cleaner extracts than conventional procedures.